Australian trader faces jail in US
AN AUSTRALIAN financial analyst is facing up to 25 years in a US jail for allegedly pocketing $7600 in an insider-trading scheme.
Trent Martin, 33, from New South Wales, was arrested in Hong Kong on December 22 on US charges relating to an alleged insider-trading scheme linked to computer company IBM's $US1.2 billion purchase of SPSS, a software company.
He faces charges of securities fraud and conspiracy to commit securities fraud, the US Attorney's Office in New York said, and could spend up to five years in prison on the conspiracy charge and up to 20 years on the securities fraud charge if convicted.
"Martin is a licensed professional who knowingly disregarded insider-trading laws to enrich himself, and then fled the United States when he learnt of our investigation," said Daniel Hawke of the US Securities and Exchange Commission.
"Martin could run but he could not hide, as the long arm of the SEC will extend to those who flee the United States hoping to avoid the consequences of their unlawful conduct."
A Department of Foreign Affairs and Trade spokesman said the Australian government was aware of Martin's arrest and officials from the consulate-general in Hong Kong planned to visit him in prison on Friday to offer consular assistance.
It is believed that Martin is on "administrative leave" from his employer, Nomura International. He joined Nomura in September 2011, and previously worked at Royal Bank of Scotland in New York and Sydney from 2009 to 2011.
Martin was alleged to have learnt confidential information from an unidentified New Zealand lawyer working on the IBM deal on May 31, 2009, when they were in New York.
The pair were identified in SEC documents as being "very close friends", with the lawyer expecting Martin not to share the information or use it to trade. The SEC added: "As two young professionals living in a foreign country far from home, they quickly became very close friends . . . The [lawyer] considered [Martin] to be his closest friend in New York."
The SEC said Martin "attempted to purchase SPSS common stock on the very first business day after learning the non-public information from his friend" in June 2009. He also shared the information with his room-mate in Manhattan, stockbroker Thomas Conradt, 34, who in turn told co-worker David Weishaus, 32, the SEC alleged.
Ahead of the IBM deal, Conradt said in an instant message conversation with Weishaus that "Trent told me not to tell anyone". On the same day, Martin allegedly told his lawyer friend he bought SPSS common stock and call options based on the information he shared with him. The lawyer "expressed outrage and demanded that Martin sell all his SPSS securities immediately", the SEC alleged.
The IBM deal was announced on July 28, 2009, and SPSS common stock rose by 41 per cent in one day.
All five alleged participants gained a total of $US1.2 million in profits, the US Attorney's Office said, adding that Martin gained $US7900, Conradt $US2538 and Weishaus $US129,290.
Two other unidentified brokers allegedly yielded profits of $US629,954 and $US254,360.
In late 2010, Martin allegedly told the lawyer he profited almost $US8000 from the information, as the SEC started its investigation into the suspected insider trading.
"Martin further stated to [the lawyer] that he was returning to Australia in light of the SEC investigation, and that he knew that insider trading can result in jail sentences, referring to the criminal prosecution of Martha Stewart," the US Attorney's Office said.
Martin appeared in a Hong Kong court on December 24 and was remanded in custody, the city's justice department said.
The department added that the case was adjourned to January 4 so he could obtain legal advice.
InvestSMART FORUM: Come and meet the team
We're loading up the van and going on tour from April to June, with events on the NSW central & north coast, the QLD mid-north coast and in Perth, Adelaide, Melbourne, Sydney and Canberra. Come and meet the team and take home simple strategies that you can use to build an investment portfolio to weather any storm. Book your spot here.
Want access to our latest research and new buy ideas?
Start a free 15 day trial and gain access to our research, recommendations and market-beating model portfolios.Sign up for free